Array Firms Debut New Products to Cash in on 'Lucrative' Sequence-Capture Market

Agilent Technologies and Febit this week separately announced expansions to their sequence capture product lines, while Roche NimbleGen discussed plans to grow its seq-cap portfolio by year end.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.